The Nasdaq Hearings Panel granted SCWorx Corp.'s request for reconsideration of its September 17 delisting decision, determining the company has regained compliance with Nasdaq's minimum bid price and publicly held shares requirements. Trading in the common stock, suspended since April 2026, will be reinstated on a date to be scheduled by Nasdaq after the company submits the required reinstatement form. As a condition of continued listing, investors in a September private placement waived their termination rights related to the prior delisting determination, and the Panel imposed a one-year Discretionary Panel Monitor ending October 2027 requiring monthly reporting on shareholdings. SCWorx Corp. provides data management solutions to healthcare providers.
